Business Weekly

GSK’s $2.2 billion RAPT acquisition shows how a constrained immunology use case can become adoption ready and commercially attractive

GSK’s $2.2 billion agreement to acquire RAPT Therapeutics highlights a practical truth about immunology: some clinically ...

ASX to rise though CSL, ASX moves could dent opening

Australian futures are pointing to a higher open; CSL plunged 5pc late on Tuesday on sudden CEO exit, ASX boss quits abruptly ...
World Wildlife Fund (WWF)

Climate Change & Nature Loss are Driving an Insurance Crisis

As climate change and nature loss accelerate, the insurance protection gap is widening, putting households and communities at ...

EU’s von der Leyen calls for bloc to ‘deepen’ the single market – as it happened

The European Commission president said the bloc should complete more trade agreements around the world ...
United States Army

Career Skills Program guides service members to new objective—civilian worklife

As service members prepare to navigate the unfamiliar terrain of post-service life, they don’t have to plot coordinates and ...

Phio Announces Safety Monitoring Committee's (SMC) Positive Wrap-up on Lead Clinical Candidate PH-762 in Skin Cancer Trial

Maximum Dose Concentration in Final Cohort Yields 85% Pathological Response (6 of 7 Patients); Complete Response (100% Tumor Clearance) in 4 of 6 RespondersNo Serious Adverse Events or Dose-Limiting ...

Robinhood Markets, Inc. (HOOD) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 10, 2026 5:00 PM ESTCompany ParticipantsVladimir Tenev - Co-Founder, President, CEO ...